Objective To investigate the clinical features of patients with decompensated liver disease complicated by acute stroke. Methods A retrospective analysis was performed for the clinical data of 15 patients who were hospitalized in Beijing You'an Hospital,Capital Medical University and diagnosed with decompensated liver disease complicated by acute stroke from January 2011 to December 2015,including medical history,neurological manifestations,treatment,and prognostic features. Results Among the 15 patients,11 had acute hemorrhagic stroke( AHS),and 4 had acute ischemic stroke( AIS); among the 11 patients with AHS,4( 36. 36%) had hemorrhage caused by brain metastatic tumor of liver cancer( tumor- associated stroke),and 3( 27. 27%) were complicated by liver failure. Among the 15 patients,12( 80%) had disturbance of consciousness as the early neurological manifestation,and the confirmed diagnosis was made based on head CT findings; the treatment mainly included symptomatic support and rehabilitation training. The patients with AHS had poor prognosis.Four( 26. 67%) of the 15 AHS patients died,among these patients,2 had liver failure complicated by AHS,1 had liver cirrhosis complicated by AHS,and 1 had brain metastases complicated by AHS. Conclusion Patients with decompensated liver disease complicated by acute stroke tend to develop the manifestations of AHS,which may be related to a poor clotting mechanism and brain metastasis of liver cancer,and have poor prognosis. Head CT scan should be performed for patients with decompensated liver disease accompanied by neuropsychiatric abnormalities as early as possible to help with early diagnosis and timely treatment.
[1]HAO ZL,LIU M,LI W,et al.Basic characteristics and functional outcomes of 3123 consecutive patients in Chengdu stroke registry[J].Chin J Neurol,2011,12(44):826-831.(in Chinese)郝子龙,刘鸣,李伟,等.成都卒中登记方法及3123例患者基本特征和功能结局[J].中华神经科杂志,2011,12(44):826-831.
|
[2]WANG Z,LI J,WANG C,et al.Gender difference in 1-year clinical characteristics and outcomes after stroke:results from the China National Stroke Registry[J].PLo S One,2013,8(2):e56459.
|
[3]STEINER T,BOSEL J.Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage[J].Stroke,2010,41(2):402-409.
|
[4]MAYER SA,RINCON F.Treatment of intraeerebral haemorrhage[J].Lancet Neurol,2005,4(10):662-672.
|
[5]JIA JD.Diagnosis and treatment of end-stage liver disease[J].Chin J Hepatol,2007,6(15):401-402.(in Chinese)贾继东.终末期肝病的诊疗现状[J].中华肝脏病杂志,2007,6(15):401-402.
|
[6] Chinese Society of Neurology and Cerebrovascular Disease Group.Guidelines for the Management of Intracerebral Hemorrhage in China[J].Chin J Neurol,2015,48(6):435-444.(in Chinese)中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国脑出血诊治指南(2014)[J].中华神经科杂志,2015,48(6):435-444.
|
[7] Chinese Society of Neurology and Cerebrovascular Disease Group.Guidelines for the management of acute ischemic stroke in China2014[J].Chin J Neurol,2015,48(4):246-257.(in Chinese)中华医学会神经病学分会中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246-257.
|
[8]DUAN ZP,CHEN Y.Treatment of commonly seen complications in end-stage liver disease[J].Clin J Hepatol,2007,15(6):458-460.(in Chinese)段钟平,陈煜.终末期肝病的常见并发症及处理[J].中华肝脏病杂志,2007,15(6):458-460.
|
[9]ZHANG HK,MENG XL,LI HL,et al.Current status of malnutrition and its association with prognosis in hospitalized patients with decompensated liver cirrhosis[J].J Clin Hepatol,2016,32(6):1100-1103.(in Chinese)张辉凯,孟祥林,李海雷,等.失代偿期肝硬化患者营养不良情况及其与预后的关系[J].临床肝胆病杂志,2016,32(6):1100-1103.
|
[10]CHOI HJ,CHO BC,SOHN JH,et al.Brain metastases from hepatocellular carcinoma:prognostic factors and outcome:brain metastasis from HCC[J].J Neurooncol,2009,91(3):307-313.
|
[11]JANG XB,KE C,ZHANG GH,et al.Brain metastases from hepatocellular carcinoma:clinical features and prognostic factors[J].BMC Cancer,2012,12:49.
|
[12]PARK ES,KWON DO H,PARK JB,et al.Gamma Knife surgery for treating brain metastases arising from hepatocellular carcinomas[J].J Neurosurg,2014,121(Suppl):102-109.
|
[13]PARK Y,KIM KS,KIM K,et al.Nomogram prediction of survival in patients with brain metastases from hepatocellular carcinoma treated with whole-brain radiotherapy:a multicenter retrospective study[J].J Neurooncol,2015,125(2):377-383.
|